Federal health regulators are weighing restrictions on Robitussin, NyQuil and other cough suppressants to curb abuse that sends thousands of people to the hospital each year.

The Food and Drug Administration on Tuesday posted its review of dextromethorphan, an ingredient in more than 100 over-the-counter medications that is sometimes abused for its euphoric effects. The practice, dubbed “robotripping,” involves taking more than 25 times the recommended dose of a cold medicine and is mainly associated with teenagers. Get the full story »